Home › Acute Myeloid Leukemia › New York

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa New York

71 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa New York.

Mga Lungsod sa New York

Opisyal na teksto ng pag-aaral (English)

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Montefiore Medical Center - Moses Campus /ID# 279399, The Bronx

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07581002

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo

Nagre-recruitPhase 2

Edad 60 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07437950

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
at 1 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1

Edad 12 hanggang 78 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Mount Sinai Hospital, New York
at 5 pa

Nagre-recruitPhase 2

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Roswell Park Comprehensive Cancer Center, Buffalo
Memorial Sloan Kettering Cancer Center, New York
New York Presbyterian - Weill Cornell, New York
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Northwell Health/Center for Advanced Medicine, Lake Success
at 9 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Roswell Park Cancer Institute, Buffalo

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06871410

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1

Hanggang edad 21 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07012044

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Northwell Health/Center for Advanced Medicine, Lake Success
at 5 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
at 1 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
at 4 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
at 9 pa

Nagre-recruitPhase 2

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06284486

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
at 11 pa

Nagre-recruitPhase 3

6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

Nagre-recruitPhase 1/2

30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Weill Cornell, New York
Clinical Research Allicance, Westbury

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06824168

A Telehealth Advance Care Planning Intervention

University of Rochester, Rochester

Nagre-recruit

Edad 60 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05875805

Cord Blood Transplant in Adults With Blood Cancers

Memorial Sloan Kettering Cancer Center, New York

Nagre-recruitPhase 2

Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05884333

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Roswell Park Comprehensive Cancer Center, Buffalo

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06969430

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York Medical College /ID# 275597, Valhalla

Nagre-recruitPhase 1

6 Months – 17 Years · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07306832

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Albany Medical Center, Albany
Montefiore Medical Center - Moses Campus, The Bronx

Nagre-recruitPhase 3

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07022678

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
at 7 pa

Nagre-recruitPhase 1/2

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center - New York, New York
Cohen Children's Medical Center, Queens

Nagre-recruitPhase 3

29 Days – 21 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

State University of New York at Buffalo, Buffalo
Icahn School of Medicine at Mount Sinai, New York
Columbia University, New York
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)

Stony Brook Cancer Center, Stony Brook

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06297551

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Comprehensive Cancer Center, Buffalo
Northwell Health, LLC PRIME, Lake Success
Memorial Sloan Kettering Cancer Center, New York
at 3 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NYU Langone Health, New York

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06656494

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

New York Presbyterian Hospital-Columbia University Medical Center, New York

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07486713

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Memorial Sloan- Kettering Cancer Center, New York

Nagre-recruitPhase 1

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06177067

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site, New York

Nagre-recruitPhase 1/2

Edad 16 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07155226

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

University of Rochester Medical Center (URMC), Rochester

Nagre-recruitPhase 3

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05429632

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
at 1 pa

Nagre-recruitPhase 2

Edad 60 pataas · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07392242

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

Roswell Park Cancer Institute, Buffalo

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05442216

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Roswell Park Cancer Institute, Buffalo
North Shore University Hospital, Lake Sucess
Cohen Children's Medical Center of New York, New Hyde
at 9 pa

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

University of Rochester Medical Center, Rochester

Nagre-recruit

Edad 60 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06697600

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Memorial Sloan Kettering Suffolk-Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
at 1 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT05756777

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.